IKZF1 alterations predict poor prognosis in adult and pediatric T-ALL

被引：15

作者：

Simonin, Mathieu ^{[1
,2
,3
]}

Lhermitte, Ludovic ^{[1
,3
]}

Dourthe, Marie-Emilie ^{[1
,3
,4
]}

Lengline, Etienne ^{[5
]}

Graux, Carlos ^{[6
]}

Grardel, Nathalie ^{[7
,8
]}

Cayuela, Jean-Michel ^{[9
,10
]}

Arnoux, Isabelle ^{[11
]}

Gandemer, Virginie ^{[12
]}

Ifrah, Norbert ^{[13
]}

Dombret, Herve ^{[5
]}

Baruchel, Andre ^{[4
]}

Macintyre, Elizabeth ^{[1
,3
]}

Petit, Arnaud ^{[2
,14
]}

Boissel, Nicolas ^{[5
]}

Asnafi, Vahid ^{[1
,3
]}

机构：

[1] Univ Paris, Lab Oncohematol, Hop Necker Enfants Malad, AP HP, Paris, France

[2] Sorbonne Univ, Armand Trousseau Hosp, AP HP, Dept Pediat Hematol & Oncol, Paris, France

[3] INSERM, Inst Necker Enfants Malad INEM, U1151, Paris, France

[4] Univ Paris Diderot, Robert Debre Hosp, AP HP, Dept Pediat Hematol & Immunol, Paris, France

[5] Univ Paris Diderot, Inst Univ Hematol, Univ Hosp St Louis, AP HP,EA 3518, Paris, France

[6] Catholic Univ Louvain, Dept Hematol, CHU UCL Namur Site Godinne, Yvoir, Belgium

[7] Ctr Hosp Reg Univ CHRU Lille, Lab Hematol, Lille, France

[8] INSERM, U1172, Lille, France

[9] Univ Paris, Univ Hosp St Louis, AP HP, Lab Hematol, Paris, France

[10] Univ Paris, Univ Hosp St Louis, AP HP, EA 3518, Paris, France

[11] Marseille Univ Hosp Timone, Hematol Lab, Marseille, France

[12] Univ Hosp Rennes, Dept Pediat Hematol & Oncol, Rennes, France

[13] Univ Nantes Angers Le Mans, PRES LUNAM, POle Rech & Enseignement Super, Ctr Hosp Univ CHU Angers,Serv Malad Sang,INSERM U, Angers, France

[14] Univ Pierre & Marie Currie Univ Paris 06, Unite Mixte Rech Sante UMRS 938, GRC MyPAC Grp Rech Clin Myeloproliferat Aigues &, Ctr Rech CDR St Antoine GRC 07, Paris, France

来源：

BLOOD | 2021年 / 137卷 / 12期

关键词：

ACUTE LYMPHOBLASTIC-LEUKEMIA; IKAROS; MUTATIONS; EVENT;

D O I：

10.1182/blood.2020007959

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1690 / 1694

页数：5

共 50 条

[21] The molecular profile of adult T-cell acute lymphoblastic leukemia: Mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL
Grossmann, Vera
Haferlach, Claudia
Weissmann, Sandra
Roller, Andreas
Schindela, Sonja
Poetzinger, Franziska
Stadler, Kathrin
Bellos, Frauke
Kern, Wolfgang
Haferlach, Torsten
Schnittger, Susanne
Kohlmann, Alexander
GENES CHROMOSOMES & CANCER, 2013, 52 (04): : 410 - 422
[22] IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan
Asai, Daisuke
Imamura, Toshihiko
Suenobu, So-ichi
Saito, Akiko
Hasegawa, Daiichiro
Deguchi, Takao
Hashii, Yoshiko
Matsumoto, Kimikazu
Kawasaki, Hirohide
Hori, Hiroki
Iguchi, Akihiro
Kosaka, Yoshiyuki
Kato, Koji
Horibe, Keizo
Yumura-Yagi, Keiko
Hara, Junichi
Oda, Megumi
CANCER MEDICINE, 2013, 2 (03): : 412 - 419
[23] CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy
Leong, Sarah
Inglott, Sarah
Papaleonidopoulou, Foteini
Orfinada, Karen
Ancliff, Philip
Bartram, Jack
Carpenter, Ben
Fielding, Adele K.
Ghorashian, Sara
Grandage, Victoria
Gupta, Rajeev
Hough, Rachael
Khwaja, Asim
Pavasovic, Vesna
Rao, Anupama
Samarasinghe, Sujith
Vora, Ajay
Mansour, Marc R.
O'Connor, David
BLOOD ADVANCES, 2020, 4 (19) : 4665 - 4668
[24] Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols
Ofverholm, I.
Tran, A. N.
Heyman, M.
Zachariadis, V.
Nordenskjold, M.
Nordgren, A.
Barbany, G.
LEUKEMIA, 2013, 27 (09) : 1936 - 1939
[25] Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia
Volejnikova, Jana
Mejstrikova, Ester
Doerge, Petra
Meissner, Barbara
Zimmermannova, Olga
Svojgr, Karel
Stanulla, Martin
Cario, Gunnar
Schrappe, Martin
Stary, Jan
Hrusak, Ondrej
Trka, Jan
Fronkova, Eva
PEDIATRIC BLOOD & CANCER, 2013, 60 (03) : 420 - 427
[26] Quantitative analysis of IKZF1 gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia: higher levels are associated with a poorer prognosis
Huang, Zhizhuo
Jia, Yueping
Ruan, Guorui
Zuo, Yingxi
Wu, Jun
Lu, Aidong
Xue, Yujuan
Cheng, Yifei
Zhang, Leping
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2022, 39 (03) : 243 - 253
[27] IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial
Mitchell, Rachel J.
Kirkwood, Amy A.
Barretta, Emilio
Clifton-Hadley, Laura
Lawrie, Emma
Lee, SooWah
Leongamornlert, Daniel
Marks, David, I
McMillan, Andrew K.
Menne, Tobias F.
Papaemmanuil, Elli
Patel, Bela
Patrick, Pip
Rowntree, Clare J.
Zareian, Nahid
Alapi, Krisztina Zuborne
Moorman, Anthony, V
Fielding, Adele K.
BLOOD ADVANCES, 2021, 5 (17) : 3322 - 3332
[28] IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia
Paolino, Jonathan
Tsai, Harrison K.
Harris, Marian H.
Pikman, Yana
BIOMEDICINES, 2024, 12 (01)
[29] Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL
Hannon, Maura M.
Lohan, Fiona
Erbilgin, Yucel
Sayitoglu, Muge
O'Hagan, Kathleen
Mills, Ken
Ozbek, Ugur
Keeshan, Karen
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (05) : 626 - 634
[30] Pediatric T-ALL complicated by irreversible nelarabine neurotoxicity
Kanayama, Takuyo
Imamura, Toshihiko
Nakagawa, Norio
Osone, Shinya
Hosoi, Hajime
PEDIATRICS INTERNATIONAL, 2017, 59 (07) : 843 - 845

← 1 2 3 4 5 →